Pittenger & Anderson Inc. Purchases 1,260 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Pittenger & Anderson Inc. raised its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXONFree Report) by 2,000.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,323 shares of the biotechnology company’s stock after purchasing an additional 1,260 shares during the quarter. Pittenger & Anderson Inc.’s holdings in Axon Enterprise were worth $342,000 at the end of the most recent reporting period.

Several other hedge funds have also added to or reduced their stakes in the business. BKM Wealth Management LLC acquired a new stake in shares of Axon Enterprise during the fourth quarter worth $32,000. Key Financial Inc lifted its stake in shares of Axon Enterprise by 367.6% in the fourth quarter. Key Financial Inc now owns 159 shares of the biotechnology company’s stock worth $41,000 after acquiring an additional 125 shares during the period. Lindbrook Capital LLC lifted its stake in shares of Axon Enterprise by 43.3% in the fourth quarter. Lindbrook Capital LLC now owns 172 shares of the biotechnology company’s stock worth $44,000 after acquiring an additional 52 shares during the period. Rakuten Securities Inc. acquired a new position in shares of Axon Enterprise in the fourth quarter worth approximately $48,000. Finally, Provence Wealth Management Group acquired a new position in Axon Enterprise in the third quarter valued at approximately $80,000. Institutional investors and hedge funds own 79.08% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on AXON. Needham & Company LLC reiterated a “buy” rating and set a $400.00 price target on shares of Axon Enterprise in a report on Wednesday. Robert W. Baird increased their price objective on Axon Enterprise from $260.00 to $300.00 and gave the company an “outperform” rating in a research report on Thursday, February 22nd. The Goldman Sachs Group raised their price target on Axon Enterprise from $297.00 to $339.00 and gave the stock a “buy” rating in a research report on Wednesday, February 28th. JPMorgan Chase & Co. raised their price target on Axon Enterprise from $330.00 to $365.00 and gave the stock an “overweight” rating in a research report on Thursday, April 11th. Finally, StockNews.com cut Axon Enterprise from a “buy” rating to a “hold” rating in a research note on Thursday, March 14th. Two equities research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $312.64.

View Our Latest Research Report on AXON

Axon Enterprise Trading Up 1.3 %

Shares of NASDAQ AXON traded up $3.83 during midday trading on Thursday, hitting $306.24. The company’s stock had a trading volume of 297,871 shares, compared to its average volume of 469,482. The company has a current ratio of 3.00, a quick ratio of 2.66 and a debt-to-equity ratio of 0.42. The business’s 50 day moving average is $302.15 and its two-hundred day moving average is $260.29. Axon Enterprise, Inc. has a 12-month low of $175.37 and a 12-month high of $329.87. The firm has a market cap of $23.11 billion, a P/E ratio of 133.72 and a beta of 0.93.

Axon Enterprise (NASDAQ:AXONGet Free Report) last released its quarterly earnings data on Tuesday, February 27th. The biotechnology company reported $0.77 EPS for the quarter, topping the consensus estimate of $0.48 by $0.29. The company had revenue of $432.14 million for the quarter, compared to the consensus estimate of $418.97 million. Axon Enterprise had a return on equity of 14.11% and a net margin of 11.14%. As a group, equities research analysts expect that Axon Enterprise, Inc. will post 2.44 EPS for the current year.

About Axon Enterprise

(Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

See Also

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXONFree Report).

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.